Remote-control tools for nerve cells that link the gut and brain
Fusion of nanomagnetic and viral tools to interrogate brain-body circuits
The team is building new tools that let researchers target and remotely control specific nerve cells in the body and brain to learn how gut signals affect mood and motivation.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11145014 on NIH RePORTER |
What this research studies
From a patient's view, the researchers are creating tiny magnetic particles and pairing them with viral delivery systems so they can find and stick to particular nerve cells anywhere in the body. Once in place, the particles can be activated by weak magnetic fields to turn those cells on or off during natural behavior. The project focuses on circuits between the gut and the brain that influence mood, stress, and motivation. Most work will be done in the lab using animal models and cell-targeting techniques developed at MIT.
Who could benefit from this research
Good fit: People with mood or affective disorders (for example depression or anxiety) interested in research about gut–brain links would be the eventual candidates for related clinical work.
Not a fit: Patients seeking immediate treatments or those with conditions unrelated to brain–gut circuits are unlikely to benefit from this basic research in the near term.
Why it matters
Potential benefit: If successful, this could lead to precise, less invasive ways to modify gut–brain signals and eventually offer new treatments for depression, anxiety, or other mood disorders.
How similar studies have performed: Elements like AAV targeting and magnetic nanoparticles have shown effects in animal experiments, but combining viral targeting with magnetic nanotransducers for body-wide, receptor-specific control is largely novel.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Anikeeva, Polina O — Massachusetts Institute of Technology
- Study coordinator: Anikeeva, Polina O
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.